$IPSC Cashflow Statement | Understand Stock

$IPSC

$1.42 -$0.04 (2.74%) Close

$IPSC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of deferred financing cost
Non-cash operating lease expense (benefit)
Stock based compensation
Warrants issued for services
Impairment
Accretion of investments
Change in fair value of contingent liabilities
Decrease in lease liability due to lease termination
Change in deferred tax liability
Gain on reduction in lease liability due to lease termination
Deferred tax (benefit) expense

Change in operating assets and liabilities:
Escrow deposit
Prepaid expenses and other assets
Operating lease liability
Deferred revenue
Accounts payable
Accrued expenses and other liabilities
Net cash used in operating activities
Cash flows from investing activities
Acquisition of property and equipment
Acquisition of fixed maturity securities, available for sale
Sale of fixed maturity securities, available for sale
Acquisition of Clade Therapeutics, Inc., net of cash acquired
Net cash provided by investing activities
Cash flows from financing activities
Proceeds from initial public offering, net of underwriting discounts and commissions
Proceeds from issuance of common stock and ESPP
Proceeds from early exercises of common stock options
Proceeds from subscription receivable
Proceeds from issuance of Series C preferred stock, net of issuance costs
Cash contributed as a result of merger
Payments on long term debt
Proceeds from issuance of shares to collaboration partner
Proceeds from ATM, net of issuance costs
Proceeds from PIPE, net of issuance costs
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Net increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of cash and non-cash operating activities:
Cash paid for interest
Reduction of ROU asset and lease liability due to non-cash lease modification
Cash paid for income tax
Supplemental disclosure of non-cash investing and financing activities:
Conversion of convertible preferred stock upon initial public offering
Purchase of property and equipment, accrued and unpaid
Issuance of Equity to satisfy contingent liability
Stock issued in connection with the Acquisition
Landlord paid leasehold improvements

Comments